Literature DB >> 18410366

The FLEP scale in diagnosing nocturnal frontal lobe epilepsy, NREM and REM parasomnias: data from a tertiary sleep and epilepsy unit.

Raffaele Manni1, Michele Terzaghi, Alessandra Repetto.   

Abstract

PURPOSE: To test the usefulness of the FLEP scale in diagnosing nocturnal frontal lobe epilepsy (NFLE), arousal parasomnias, and REM sleep behavior disorder (RBD).
METHODS: The FLEP scale was applied to 71 subjects (60 male; 11 female; aged 54 +/- 21) referred to an outpatient's sleep and epilepsy unit for diagnostic assessment of nocturnal motor-behavioral episodes, which turned to be arousal parasomnias (11 subjects), NFLE (14 subjects), or idiopathic RBD (46 subjects), based on the findings of in-lab full night video polysomnography with extended EEG montages.
RESULTS: The sensitivity of the scale as a diagnostic test for NFLE was 71.4%, the specificity 100%, the positive predictive value 100%, and the negative predictive value 91.1%. The FLEP scale gave an incorrect diagnosis in 4/71 (5.6%) of the cases, namely NFLE patients with episodes of nocturnal wandering, and uncertain diagnostic indications in 22/71 subjects (30.9%).
CONCLUSIONS: The FLEP scale shows high positive and negative predictive values in diagnosing NFLE versus arousal parasomnias and RBD. However, the scale is associated with a real risk of misdiagnosis in some patients and gives uncertain indications in about one-third of cases, mainly RBD. Our investigation highlights the inadequacy of some of the items in the scale. The item investigating wandering, as presently formulated, may be unable to distinguish nocturnal wandering from sleepwalking. The items about "recall" and "clustering" of the events throughout the night may increase the likelihood of mistaking RBD for seizures. Further testing of the reliability of the FLEP scale items appears to be needed.

Entities:  

Mesh:

Year:  2008        PMID: 18410366     DOI: 10.1111/j.1528-1167.2008.01602.x

Source DB:  PubMed          Journal:  Epilepsia        ISSN: 0013-9580            Impact factor:   5.864


  19 in total

Review 1.  Diagnostic tools for REM sleep behavior disorder.

Authors:  Ariel B Neikrug; Sonia Ancoli-Israel
Journal:  Sleep Med Rev       Date:  2011-12-14       Impact factor: 11.609

Review 2.  Nocturnal frontal lobe epilepsy.

Authors:  Lino Nobili; Paola Proserpio; Romina Combi; Federica Provini; Giuseppe Plazzi; Francesca Bisulli; Laura Tassi; Paolo Tinuper
Journal:  Curr Neurol Neurosci Rep       Date:  2014-02       Impact factor: 5.081

3.  Can homemade video recording become more than a screening tool?

Authors:  Lino Nobili
Journal:  Sleep       Date:  2009-12       Impact factor: 5.849

Review 4.  The sleep manifestations of frontal lobe epilepsy.

Authors:  Christopher P Derry
Journal:  Curr Neurol Neurosci Rep       Date:  2011-04       Impact factor: 5.081

5.  Video analysis of epileptic-like motor patterns in REM behaviour disorder: a case series.

Authors:  Loretta Giuliano; Daniela Fatuzzo; Greta Mainieri; Vito Sofia; Mario Zappia
Journal:  Neurol Sci       Date:  2016-12-17       Impact factor: 3.307

Review 6.  [Sleep disorders in neurological diseases].

Authors:  S Kotterba
Journal:  Nervenarzt       Date:  2015-06       Impact factor: 1.214

7.  Violent behavior during sleep: prevalence, comorbidity and consequences.

Authors:  Maurice M Ohayon; Carlos H Schenck
Journal:  Sleep Med       Date:  2010-10       Impact factor: 3.492

8.  Scalp and Source Power Topography in Sleepwalking and Sleep Terrors: A High-Density EEG Study.

Authors:  Anna Castelnovo; Brady A Riedner; Richard F Smith; Giulio Tononi; Melanie Boly; Ruth M Benca
Journal:  Sleep       Date:  2016-10-01       Impact factor: 5.849

9.  Nocturnal Frontal Lobe Epilepsy vs Parasomnias.

Authors:  Christopher Derry
Journal:  Curr Treat Options Neurol       Date:  2012-10       Impact factor: 3.598

Review 10.  Sleep and Epilepsy: a Focused Review of Pathophysiology, Clinical Syndromes, Co-morbidities, and Therapy.

Authors:  J Layne Moore; Diego Z Carvalho; Erik K St Louis; Carl Bazil
Journal:  Neurotherapeutics       Date:  2021-03-30       Impact factor: 7.620

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.